← Back to Search

Voice adaptive training for aphasia for Aphasia (VoiceAdapt Trial)

N/A
Waitlist Available
Led By Esther S Kim, PhD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 weeks; 13 weeks
Awards & highlights

VoiceAdapt Trial Summary

This trial found that the VoiceAdapt app was an innovative and motivating way to provide training for people with aphasia that led to long-term engagement.

VoiceAdapt Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 weeks; 13 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 weeks; 13 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in naming on the Boston Naming Test (BNT)
Secondary outcome measures
Change in Aphasia Quotient on the Western Aphasia Battery-Revised (WAB-R)
Change in score on the Communication Effectiveness Index (CETI)
Change in score on the Stroke and Aphasia Quality of Life Scale (SAQOL-39)
Other outcome measures
Situation Motivation Scale (SIMS) score

VoiceAdapt Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: VoiceAdapt InterventionExperimental Treatment1 Intervention
PWA who train with VoiceAdapt app
Group II: No InterventionActive Control1 Intervention
PWA who are on the waitlist and not training with VoiceAdapt app
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Voice adaptive training for aphasia
2020
N/A
~40

Find a Location

Who is running the clinical trial?

University of TorontoOTHER
689 Previous Clinical Trials
1,018,605 Total Patients Enrolled
University of AlbertaLead Sponsor
886 Previous Clinical Trials
384,740 Total Patients Enrolled
Technische Universität BerlinOTHER
12 Previous Clinical Trials
686,217 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment still open for participation in this research program?

"According to clinicaltrials.gov, this medical investigation is not presently enrolling participants. The trial was initially advertised on October 1st 2020 but has since been updated on the 31st of October 2022. Although recruitment for this study has ceased at present, 86 other trials are currently accepting applications from patients."

Answered by AI

Who else is applying?

What state do they live in?
California
How old are they?
65+
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
JMIR Research ProtocolsJournal
Implementation and Effects of an Information Technology–based Intervention to Support Speech and Language Therapy Among Stroke Patients with Aphasia: Protocol for a Virtual Randomized Controlled Trial
Kim, Esther S, Laura Laird, Carlee Wilson, Till Bieg, Philip Mildner, Sebastian Möller, Raimund Schatz, et al.. 2021. “Implementation and Effects of an Information Technology–based Intervention to Support Speech and Language Therapy Among Stroke Patients with Aphasia: Protocol for a Virtual Randomized Controlled Trial”. JMIR Research Protocols. JMIR Publications Inc.. doi:10.2196/30621.
clinicaltrials.govStudy
Voice Adaptive Tablet-Based Naming Treatment for Adults With Aphasia
Esther Kim 2020. "Voice Adaptive Tablet-Based Naming Treatment for Adults With Aphasia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04108364.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top